Alzheimer's amyloid immunotherapy: quo vadis?
Gandy
Sam
S
Heppner
Frank L
FL
D000544:Alzheimer Disease / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D023582:Alzheimer Vaccines / Q000627:therapeutic use*; D016229:Amyloid beta-Peptides / Q000276:immunology*; D000818:Animals; D001921:Brain / Q000473:pathology*; D002986:Clinical Trials as Topic; D006801:Humans; D016233:Immunotherapy, Active / Q000009:adverse effects
D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides